Tumor Angiogenesis: Initiation and Targeting - Therapeutic Targeting of an FGF-Binding Protein, an Angiogenic Switch Molecule, and Indicator of Early Stages of Gastrointestinal Adenocarcinomas -

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2006.38.4.189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Cancer Association

Related search

Nanotechnology-Mediated Targeting of Tumor Angiogenesis

Vascular Cell
Computer NetworksDevelopmental NeuroscienceNeurologyCell BiologyCommunications
2011English

Targeting Angiogenesis in Gastrointestinal Tumors: Current Challenges

Translational Gastroenterology and Hepatology
2016English

Therapeutic Targeting of Tumor Associated Macrophages.

English

Triggering Tumor Immunity Through Angiogenesis Targeting

Clinical Cancer Research
Cancer ResearchOncology
2007English

Small-Molecule Targeting of Translation Initiation for Cancer Therapy

Oncotarget
Oncology
2013English

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2019English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Golgi Targeting of Human Guanylate-Binding Protein-1 Requires Nucleotide Binding, Isoprenylation, and an IFN- -Inducible Cofactor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Heparin-Binding Protein: An Early Indicator of Critical Illness and Predictor of Outcome in Cardiac Arrest

Resuscitation
Emergency NursingEmergency MedicineCardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy